92 related articles for article (PubMed ID: 24564630)
21. [Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Li J; Zhang Y; Wang J; Feng P; Chen R; Cao Y; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):403-7. PubMed ID: 24754980
[TBL] [Abstract][Full Text] [Related]
22. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
24. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
Wiemer J; Scherberich JE
MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two low-molecular weight heparins (LMWHs), tinzaparin and bemiparin, during hemodialysis.
Christidou FN; Frangia TK; Bamichas GI; Gionanlis LC; Natse TA; Georgoulis IE; Sombolos KI
Int J Clin Pharmacol Ther; 2005 Jul; 43(7):335-8. PubMed ID: 16035376
[TBL] [Abstract][Full Text] [Related]
26. Effects of low molecular weight heparin on the frequencies of intradialytic arrhythmias in hemodialysis patients.
Miyauchi H; Matsumoto Y; Futenma A; Amano I; Miyauchi J; Matsuo S
Ren Fail; 2006; 28(6):469-74. PubMed ID: 16928615
[TBL] [Abstract][Full Text] [Related]
27. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis.
Akiba T; Tachibana K; Ozawa K; Chida Y; Ogasawara H; Yoshiyama N; Hoshino M; Inada T; Marumo F
ASAIO J; 1992; 38(3):M326-30. PubMed ID: 1333845
[TBL] [Abstract][Full Text] [Related]
28. Dialysis Modalities and HDL Composition and Function.
Holzer M; Schilcher G; Curcic S; Trieb M; Ljubojevic S; Stojakovic T; Scharnagl H; Kopecky CM; Rosenkranz AR; Heinemann A; Marsche G
J Am Soc Nephrol; 2015 Sep; 26(9):2267-76. PubMed ID: 25745027
[TBL] [Abstract][Full Text] [Related]
29. Improvement of plasma lipoprotein profiles during high-flux dialysis.
Seres DS; Strain GW; Hashim SA; Goldberg IJ; Levin NW
J Am Soc Nephrol; 1993 Jan; 3(7):1409-15. PubMed ID: 8439653
[TBL] [Abstract][Full Text] [Related]
30. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
31. Influence of trauma on plasma elimination of exogenous fat and on lipoprotein lipase activity and mass.
Thörne A; Aberg W; Carneheim C; Olivecrona T; Nordenström J
Clin Nutr; 2005 Feb; 24(1):66-74. PubMed ID: 15681103
[TBL] [Abstract][Full Text] [Related]
32. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
[TBL] [Abstract][Full Text] [Related]
33. [Extent of coronary sclerosis in relation to lipoprotein lipase activity and plasma triglyceride levels].
Breier C; Mühlberger V; Herold M; Drexel H; Lisch HJ; Knapp E; Braunsteiner H
Schweiz Med Wochenschr; 1985 Sep; 115(37):1263-7. PubMed ID: 4059897
[TBL] [Abstract][Full Text] [Related]
34. Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.
Arnadottir M; Thysell H; Dallongeville J; Fruchart JC; Nilsson-Ehle P
Kidney Int; 1995 Sep; 48(3):779-84. PubMed ID: 7474664
[TBL] [Abstract][Full Text] [Related]
35. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
[TBL] [Abstract][Full Text] [Related]
36. Anti-Xa activity supports using a simple dosing algorithm for tinzaparin for anticoagulation in hemodialysis.
Kirwan CJ; Baig ZF; Platton S; MacCullum PK; Ashman N
Nephron Clin Pract; 2013; 123(1-2):7-12. PubMed ID: 23751953
[TBL] [Abstract][Full Text] [Related]
37. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
38. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
Kronenberg F; König P; Lhotta K; Steinmetz A; Dieplinger H
Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
[TBL] [Abstract][Full Text] [Related]
39. No difference in nitrogen balance between standard prescriptions of hemodialysis and peritoneal dialysis.
Lu Q; Cheng L; Axelsson J; Lindholm B; Wang T
Blood Purif; 2008; 26(6):511-7. PubMed ID: 18931478
[TBL] [Abstract][Full Text] [Related]
40. Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.
Applebaum DM; Goldberg AP; Pykälistö OJ; Brunzell JD; Hazzard WR
J Clin Invest; 1977 Apr; 59(4):601-8. PubMed ID: 845252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
